Hall FL - Search Results

1

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor.

Hall FL, Liu L, Zhu NL, Stapfer M, Anderson WF, Beart RW, Gordon EM. Hall FL, et al. Hum Gene Ther. 2000 May 1;11(7):983-93. doi: 10.1089/10430340050015293. Hum Gene Ther. 2000. PMID: 10811227

2

Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX.

Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson WF, Hall FL. Gordon EM, et al. Among authors: hall fl. Hum Gene Ther. 1997 Jul 20;8(11):1385-94. doi: 10.1089/hum.1997.8.11-1385. Hum Gene Ther. 1997. PMID: 9295133

3

Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice.

Chen DS, Zhu NL, Hung G, Skotzko MJ, Hinton DR, Tolo V, Hall FL, Anderson WF, Gordon EM. Chen DS, et al. Among authors: hall fl. Hum Gene Ther. 1997 Sep 20;8(14):1667-74. doi: 10.1089/hum.1997.8.14-1667. Hum Gene Ther. 1997. PMID: 9322869

4

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.

Hall FL, Gordon EM, Wu L, Zhu NL, Skotzko MJ, Starnes VA, Anderson WF. Hall FL, et al. Hum Gene Ther. 1997 Dec 10;8(18):2183-92. doi: 10.1089/hum.1997.8.18-2183. Hum Gene Ther. 1997. PMID: 9449372

5

Inhibition of rabbit keratocyte and human fetal lens epithelial cell proliferation by retrovirus-mediated transfer of antisense cyclin G1 and antisense MAT1 constructs.

Kampmeier J, Behrens A, Wang Y, Yee A, Anderson WF, Hall FL, Gordon EM, McDonnell PJ. Kampmeier J, et al. Among authors: hall fl. Hum Gene Ther. 2000 Jan 1;11(1):1-8. doi: 10.1089/10430340050016102. Hum Gene Ther. 2000. PMID: 10646634

6

Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.

Liu L, Anderson WF, Beart RW, Gordon EM, Hall FL. Liu L, et al. Among authors: hall fl. J Virol. 2000 Jun;74(11):5320-8. doi: 10.1128/jvi.74.11.5320-5328.2000. J Virol. 2000. PMID: 10799609 Free PMC article.

7

Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct.

Gordon EM, Liu PX, Chen ZH, Liu L, Whitley MD, Gee C, Groshen S, Hinton DR, Beart RW, Hall FL. Gordon EM, et al. Among authors: hall fl. Cancer Res. 2000 Jul 1;60(13):3343-7. Cancer Res. 2000. PMID: 10910035

8

Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis.

Hall FL, Kaiser A, Liu L, Chen ZH, Hu J, Nimni ME, Beart RW Jr, Gordon EM. Hall FL, et al. Int J Mol Med. 2000 Dec;6(6):635-43. doi: 10.3892/ijmm.6.6.635. Int J Mol Med. 2000. PMID: 11078822

9

Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.

Gordon EM, Chen ZH, Liu L, Whitley M, Liu L, Wei D, Groshen S, Hinton DR, Anderson WF, Beart RW Jr, Hall FL. Gordon EM, et al. Among authors: hall fl. Hum Gene Ther. 2001 Jan 20;12(2):193-204. doi: 10.1089/104303401750061258. Hum Gene Ther. 2001. PMID: 11177556

10

Lesion-targeted injectable vectors for vascular restenosis.

Gordon EM, Zhu NL, Forney Prescott M, Chen ZH, Anderson WF, Hall FL. Gordon EM, et al. Among authors: hall fl. Hum Gene Ther. 2001 Jul 1;12(10):1277-87. doi: 10.1089/104303401750270931. Hum Gene Ther. 2001. PMID: 11440621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters